March 27th 2024, 3:00pm
Patients with inoperable kidney cancer saw significant results in local control and cancer-specific survival with stereotactic ablative body radiotherapy.
March 21st 2024, 5:00pm
When life hands you cancer lemons, what flavored lemonade do you make?
March 15th 2024, 9:00pm
Quality of life, sexual outcomes and self-image should be considered before choosing a treatment option for muscle-invasive bladder cancer, an expert said.
March 15th 2024, 3:00pm
From Oliva Munn and Christine Brinkley discussing their cancer to Donnie Iris returning to the stage after his experience with the disease, here is what’s happening in the oncology space this week.
March 12th 2024, 3:00pm
Artificial intelligence platform ChatGPT is capable of providing “widely understandable and accessible” answers about kidney cancer, but experts express caution.
March 12th 2024, 1:00pm
My prostate cancer has come back and stronger, but so have I.
March 7th 2024, 5:29pm
The Food and Drug Administration (FDA) has approved Opdivo (nivolumab) in combination with cisplatin and gemcitabine for the first-line treatment of adults with unresectable or metastatic bladder cancer, the agency has announced.
February 27th 2024, 10:00pm
A phase 2 trial showed that Trodelvy plus Keytruda had a high response rate with lasting responses, emphasizing “potential additive or synergistic effects,” an expert said.
February 27th 2024, 6:00pm
Looking back on my experience with testicular cancer at a young age, I realize that cancer didn't define me — it helped shape me.
February 27th 2024, 2:00pm
Patients with locally advanced penile squamous cell carcinoma who responded to neoadjuvant chemotherapy followed by consolidative lymphadenectomy experienced improved long-term survival outcomes.
FDA Approves Imfinzi Plus Chemo in GC/GEJC
More Than a Cyst: The Fear Cancer Leaves Behind
Basics of Squamous Cell Bladder Cancer
AVZO-103 Wins FDA Designation for Previously Treated Urothelial Cancer